2 hours Rocket Pharmaceuticals (NASDAQ:RCKT) Receives New Coverage from Analysts at ScotiabankMarketBeat
Scotiabank assumed coverage on Rocket Pharmaceuticals in a research report on Wednesday. They set a “sector outperform” rating on the stock.
Nasdaq 100 · Pharmaceuticals · Science · Scotiabank
X